GLP-1s Linked to Systemic Clinical Risk Reduction in Hidradenitis Suppurativa

(MedPage Today) — Patients with hidradenitis suppurative (HS) and a history of GLP-1 receptor agonist use for diabetes or obesity had significantly lower rates of multiple cardiovascular events and mortality, a large retrospective cohort study…